Bio Path | BPTH - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Baxter International USD 517M 549K 2026-06
Bio Path USD 9.34M 100K 2026-03
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1000 2026-03
CSL USD 482.13M 93.87M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03